NCT00095446已完成4 期
An Open-Label, Multi Center, Clinical Trial: External Continuous Subcutaneous Infusion of Insulin Using Insulin Aspart (NovoLog®) in Subjects With Type 1 and Insulin Requiring Type 2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 513
- 试验地点
- 2
- 主要终点
- Treatment satisfaction with insulin pump therapy
研究概览
简要总结
This trial is conducted in the United States of America (USA). The aim of this trial is to assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to insulin lispro, both in insulin pumps, in standard clinical practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •People with Type I or Type II Diabetes
- •18 Years or Older.
排除标准
- 未提供
结局指标
主要结局
Treatment satisfaction with insulin pump therapy
次要结局
- Insulin dose
- infusion set in-use times
- body weight
- Overall glycemic control
- number and types of infusion sets used.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00097279Novo Nordisk A/S230
已完成
4 期
Novofine Autocover Safety Needle Versus BD Safety GlideHealthcare ProfessionalsDelivery SystemsDiabetesNCT00121355Novo Nordisk A/S83
已完成
3 期
Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsDelivery SystemsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT00773279Novo Nordisk A/S242
已完成
4 期
Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major SurgeryCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With InhibitorsNCT01561391Novo Nordisk A/S36
已完成
1 期
Effect of Renal Impairment on the Pharmacokinetics of NN9535Renal ImpairmentDiabetesDiabetes Mellitus, Type 2NCT00833716Novo Nordisk A/S62